Brief: NRx Pharmaceuticals Announces Definitive Purchase Agreement For Preferred Shares At $0.40 Per Share
29/08/2023 12:13
Aug 29 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX PHARMACEUTICALS ANNOUNCES DEFINITIVE PURCHASE
AGREEMENT FOR
PREFERRED SHARES AT $0.40 PER SHARE
* NRX PHARMACEUTICALS: SHARE PURCHASE TO ASSIST CO IN
DEVELOPMENT
OF NRX-101 IN SUICIDAL BIPOLAR DEPRESSION, CHRONIC PAIN, GENERAL
CORPORATE PURPOSES
* NRX PHARMACEUTICALS: ENTERED INTO AGREEMENT WITH
ACCREDITED
INVESTORS TO PURCHASE 3 MILLION SHARES OF PREFERRED STOCK
Source text for Eikon: ID:nPn6hTzSna
Further company coverage: NRXP.O
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview